首页> 美国卫生研究院文献>OncoTargets and therapy >Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center retrospective cohort study

【2h】

Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center retrospective cohort study

机译：难治性急性髓细胞性白血病和中高危骨髓增生异常综合征的剂量增强联合启动方案：单中心回顾性队列研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

ObjectiveTo assess chemotherapeutic regimens for refractory acute myeloid leukemia (AML) and middle-and-high-risk myelodysplastic syndrome (MDS).

机译：目的评估难治性急性髓细胞白血病（AML）和中高危骨髓增生异常综合症（MDS）的化疗方案。

著录项

期刊名称 OncoTargets and therapy
作者
Xiaorong Ma; Jin Wang; Yan Xu; Wanggang Zhang; Jie Liu; Xingmei Cao; Aili He; Fangxia Wang; Liufang Gu; Bo Lei; Jianli Wang;
展开▼
作者单位

展开▼
年(卷),期 2016(9),-1
年度 2016
页码 3661–3669
总页数 9
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
priming chemotherapy acute myeloid leukemia myelodysplastic syndrome B7.1;

机译：引发化学疗法;急性髓性白血病;骨髓增生异常综合症;B7.1;

相似文献

外文文献
中文文献
专利

1. Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study [J] . Xiaorong Ma, Jin Wang, Yan Xu, OncoTargets and therapy . 2016,第2期

机译：难治性急性髓细胞性白血病和中高危骨髓增生异常综合征的剂量增强联合启动方案：单中心，回顾性队列研究
2. Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome [J] . LINGYUN WU, XIAO LI, JIYING SU Leukemia and lymphoma . 2009,第9期

机译：低剂量阿糖胞苷，高灵敏素和粒细胞集落刺激因子启动方案对晚期骨髓增生异常综合征或由骨髓增生异常综合征转化的急性髓细胞白血病患者的影响
3. Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming with Decitabine in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS): Final Results from a Phase 1/2 Study [J] . Halpern Anna B., Buckley Sarah A., Othus Megan, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：在具有复发/难治性急性髓性白血病（AML）或高风险髓细胞增强综合征（MDS）的成年人中与乳蛋白酶的乳尾碱（MEC）在成人中，依甲酸酯灌注（MEC）在成人中进行表观诱发灌注术后：来自阶段1/2研究的最终结果
4. Ras gene mutation in acute myeloid leukemia and Myelodysplastic syndromes: a meta-analysis of its occurrence and prognostic relevance [C] . Cheng Jingru, Wang Peng, Zhang Tai, International Conference on Advanced Materials and Computer Science . 2016

机译：RAS基因突变在急性髓性白血病和髓细胞增强综合征中：荟萃分析其发生和预后相关性
5. Myelodysplastic Syndrome Progression to Acute Myeloid Leukemia at the Stem Cell Level [D] . Chen, Jiahao. 2018

机译：在干细胞水平上骨髓增生异常综合征进展为急性髓细胞性白血病
6. Complete Remission of a Refractory Acute Myeloid Leukemia with Myelodysplastic- and Monosomy 7-Related Changes after a Combined Conditioning Regimen of Plerixafor Cytarabine and Melphalan in a 4-Year-Old Boy: A Case Report and Review of Literature [O] . Antonio G. Grasso, Marilena Granzotto, Davide Zanon, 2018

机译：4岁男孩Plerixafor阿糖胞苷和美法仑联合调理方案后难治性急性髓性白血病的完全缓解与骨髓增生异常和单体性7相关的改变：一例病例并文献复习
7. Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study [O] . Xiaorong Ma, Jin Wang, Yan Xu, 2016

机译：剂量增强的难治性急性髓性白血病和中高风险髓细胞增强综合征的组合灌注方案：单中心，回顾性队列研究

Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center retrospective cohort study

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅